Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Focus op bijwerkingen immuuntherapie bij kanker
apr 2024 | Immuuntherapie
okt 2020
apr 2020 | Transplantatie
apr 2020
jan 2020 | Leukemie